Asset retirement obligations for radioactive and hazardous medical equipment

Radioactive and hazardous medical equipment creates a real, legally mandated decommissioning obligation decades before it is settled; failing to provide for it upfront understates liabilities for the entire operating life of the asset and defers a large, foreseeable cost recognition to a single future period, distorting long-run profitability trends for facilities using this equipment.

Does regulatory licensing for radioactive material use impose a legal obligation on the entity to decommission and safely dispose of the equipment and shielding, rather than this being a discretionary future intention? Can the future decommissioning and decontamination cost be estimated reliably at the time the asset is installed, based on regulatory guidance or vendor/specialist quotes? Has the obligation been re-measured for changes in the estimated timing, cost or discount rate since initial recognition, with the adjustment made against the related asset?

1) At the point radioactive/hazardous equipment is installed and licensed, confirm whether regulatory licensing imposes a legal obligation to decommission and dispose of the equipment and associated shielding safely. 2) If so, estimate the future decommissioning and decontamination cost reliably, drawing on regulatory requirements, engineering estimates and comparable facility experience. 3) Recognize a provision at the present value of the best estimate of this future cost at the point the obligation arises (typically installation/licensing), simultaneously capitalizing an equivalent amount as part of the cost of the related item of PP&E. 4) Depreciate the capitalized decommissioning cost over the same useful life as the related asset. 5) Unwind the discount on the provision each period as an interest/finance expense, increasing the provision toward its undiscounted settlement value over time. 6) Re-measure the provision for changes in the estimated timing, cost or discount rate, adjusting the corresponding asset (subject to not reducing the asset below nil; any excess decrease goes to profit or loss).

Measure the provision at the present value of the best estimate of the expenditure required, using a discount rate reflecting current market assessments of the time value of money and risks specific to the obligation (a pre-tax rate that does not double-count risks already reflected in the cash flow estimates); unwind the discount as an interest/finance expense each period; adjust the provision (with a corresponding asset adjustment, subject to the asset's carrying amount not going below nil) for changes in estimated cash flows, timing, or discount rate.

Disclose the nature of the decommissioning obligation, the discount rate and key assumptions used (timing, cost estimate basis, regulatory requirements relied on); disclose the carrying amount of the associated asset retirement provision and its movements during the period (unwinding of discount, re-measurements, amounts utilized); disclose the amount capitalized as part of the related asset's cost.

• Failing to recognize any decommissioning provision for radioactive equipment until actual decommissioning begins, understating liabilities and asset cost over the equipment'
• s entire life
• expensing the estimated decommissioning cost immediately instead of capitalizing it as part of the asset
• not re-measuring the provision for revisions in regulatory disposal requirements or cost estimates as they become known
• using a discount rate that does not reflect current market assessments and risks specific to the long-dated obligation
• forgetting to unwind the discount as a periodic finance expense, understating both the provision and finance costs over time.